Phase Forward to Present at the UBS Global Life Sciences Conference
September 16 2009 - 4:05PM
Business Wire
Phase Forward (NASDAQ: PFWD), a leading provider of data
management solutions for clinical trials and drug safety, today
announced its chairman and chief executive officer, Bob Weiler, and
senior vice president and chief financial officer, Chris Menard,
will present at the UBS Global Life Sciences Conference at the
Grand Hyatt Hotel in New York City.
The Phase Forward presentation is scheduled for Wednesday,
September 23, 2009 at 10:00 a.m. ET. The presentation will be
webcast live and will be available by visiting the Investors
section of the company’s website at www.phaseforward.com. The
webcast will be archived on the company’s website for 30 days after
the conference ends.
About Phase Forward
Phase Forward is a leading provider of integrated data
management solutions for clinical trials and drug safety. Phase
Forward’s products and services have been utilized in over 10,000
clinical trials involving more than 1,000,000 clinical trial study
participants at over 290 organizations and regulatory agencies
worldwide including: AstraZeneca, Boston Scientific, Dana-Farber
Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration,
GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono,
Novartis, Novo Nordisk, PAREXEL International, Procter &
Gamble, Quintiles, sanofi-aventis, Schering-Plough Research
Institute, Servier, SGS, Tibotec and the U.K. Medicines and
Healthcare Products Regulatory Agency. Additional information about
Phase Forward is available at www.phaseforward.com.
Phase Forward (NASDAQ:PFWD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Phase Forward (NASDAQ:PFWD)
Historical Stock Chart
From Jul 2023 to Jul 2024